Dutch Chipmaker Nexperia Sues Chinese Parent Firm for Two Billion Dollars

2026-11-05 semicon

Nijmegen, Thursday, 5 November 2026.
Nexperia has filed a massive two-billion-dollar lawsuit against parent firm Wingtech, alleging its Chinese owner secretly built a competing domestic supply chain that bypassed global executive control.

Semiconductor Foundations and Operational Technology

The conflict centers squarely on the traditional semiconductor industry rather than emerging frontiers like quantum computing or integrated photonics [2][3][GPT]. The microelectronics sector manufactures essential semiconductor components, such as discrete logic, transistors, and diodes, which operate by modulating electric currents across solid silicon wafers [GPT]. These basic chips regulate voltage, switch circuits, and control signals across mission-critical subsystems [2][3][GPT]. The distinct benefit of these widespread, standard semiconductors lies in their functional reliability, energy efficiency, and cost-effective scalability for widespread industrial manufacturing, serving as foundational building blocks rather than high-performance processing units [2][3][GPT].

Corporate Roots and Global Infrastructure

The enterprise responsible for producing these foundational microelectronics is Nexperia, which is headquartered in Nijmegen in the eastern Netherlands [1][2]. The manufacturer supports an international workforce exceeding 12,500 employees worldwide, with approximately 400 specialized personnel based directly at its Nijmegen operational facilities [2]. Nexperia’s output primarily serves global automotive assembly lines and consumer electronics, providing critical microchips that manage vehicle electronic architectures, drive assistance systems, and consumer hardware [2][3]. The company’s Chinese owner, Wingtech Technology, is led by founder and former chief executive Zhang Xuezheng, who is also known in the industry as ‘Mr. Wing’ [1][4][6].

Amsterdam Court Filings and Governance Fractures

Legal proceedings surfaced on Tuesday, November 3, 2026, when Wingtech publicly disclosed that Nexperia had initiated action in the Amsterdam District Court (Rechtbank Amsterdam) [1][2][7]. The lawsuit targets parent firm Wingtech, founder Zhang Xuezheng, and two Chinese operating entities identified as Nexperia China and Nexperia Shanghai [1][3][7]. Nexperia’s management confirmed the action via a brief statement, citing substantial operational damages suffered by the global firm [2][6]. According to Wingtech’s disclosures, Nexperia’s compensation demand exceeds $2 billion, which Wingtech evaluated at approximately €1.7 billion [2] or roughly €1.8 billion [6][7], representing a conversion value of 0.85 or 0.9 dollars per euro.

Supply Chain Diversion and Commercial Disputes

The core of the legal complaint focuses on allegations that the Chinese entities broke internal operational pacts and operated completely outside the corporate governance framework of Nexperia [3][7][8]. Court records indicate that since October 2025, Nexperia’s Chinese arms operated independently from the worldwide corporate structure, refusing to follow instructions issued by Nexperia’s global executive management [6][8]. Furthermore, Nexperia alleges that the defendants actively engineered a separate domestic supply chain in China, fostering direct competition and inflicting severe losses, which constitutes unfair commercial trading under Dutch law [2][3][8]. Nexperia’s $2 billion claim specifically encompasses the structural loss of a factory in China alongside substantial lost corporate revenue [8].

State Interventions and Global Retaliation

The roots of the corporate rupture trace back to September 2025, when the Dutch government intervened using historic 1952 legislation to prevent strategic assets, production capacity, and technical knowledge from being transferred to China [2][6][7]. In October 2025, the Enterprise Chamber of the Amsterdam Court of Appeal (Ondernemingskamer) suspended CEO Zhang Xuezheng following allegations concerning the illicit transfer of trade secrets and placed almost all voting rights tied to Wingtech’s shares under independent administration [1][7]. In February 2026, the Amsterdam court sustained the executive suspension and maintained the voting rights freeze while ordering a formal investigation into Nexperia’s corporate governance [1][2].

Bilateral Escalation and Cross-Border Arbitrations

Geopolitical countermeasures unfolded quickly after the initial management freeze. On October 14, 2025, Chinese authorities imposed export controls on Nexperia microchips packaged at an assembly facility in Dongguan, triggering severe component shortages for international automotive manufacturers [1][2][6]. The export bottlenecks, which also affected operations at a Shanghai factory around November 1, 2025, subsided after bilateral talks led to relaxed trade measures around November 19, 2025 [1][2][3]. However, the legal rift intensified throughout 2026. On May 23, 2026, Wingtech initiated litigation in China against three Dutch Nexperia entities and three corporate executives, demanding 8 billion yuan—worth roughly $1.2 billion [1] or €1 billion [2]—while launching an $8 billion international arbitration claim against the Dutch state [6][7]. Wingtech also recorded a write-down of 8.95 billion yuan on its Nexperia equity holding [7].

Asset Freezes and Pending Legal Proceedings

Judicial friction worsened in August 2026 when a Chinese court ordered the freezing of up to 2.14 billion yuan (approximately $300 million or €270 million) in Nexperia-held assets and shares across five Chinese subsidiaries [1][2]. Facing Nexperia’s November 2026 lawsuit in Amsterdam, Wingtech firmly denied all allegations and stated it is preparing to retain international legal counsel to defend itself once formal summons are officially served and accepted by the court [2][3][7]. As of Thursday, November 5, 2026, the Amsterdam court has not yet established an official hearing date [7][8].

Bronnen

Semiconductor litigation Corporate governance